We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Helps manufacturers and healthcare professionals understand the definition of assistive technology and the difference between medical devices and aids to daily living.
Labelling requirements for e-liquids.
A summary of actions related to problems with T34 syringe drivers
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Our Patient Involvement Strategy sets out how we will engage and involve the public and patients at every step of the regulatory journey.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
summary
Information relating to the disapplication of falsified medicines under UK Law.
Guidance for healthcare establishments that manufacture medical devices in-house.
Outlines the aim, scope and definitions of the medical technology innovation classification framework.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.
VDEC’s Discovery and surveillance capabilities provide unique services across a spectrum of molecular immunology platforms.
Actions that trial sponsors should consider to build resilience into clinical trial design
Industry must notify the MHRA if they will not be using these flexibilities
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).